Author: Pavetits, H.
Paper Title Page
TUPHA064 The LIGHT Control and Interlock Systems 543
 
  • R. Moser, H. Pavetits
    ADAM SA, Geneva, Switzerland
 
  LIGHT (Linac Image Guided Hadron Technology) is a particle therapy system* developed by Advanced Oncotherapy plc. Accelerator, control and interlock systems are developed by its subsidiary A.D.A.M. SA, a CERN spin-off. The system is being designed to accelerate protons up to 230 MeV using a modular and compact 25-meter-long linear accelerator. It is being designed to operate in pulsed mode where beam properties (energy, pulse charge and spot size) can be changed at 200 Hz. The LIGHT product will be installed in different facilities. As such, the installations will differ in accelerator and beam transfer line layouts, number of treatment rooms (with an optional gantry), facility services, equipment suppliers and equipment versions. Thus the control and interlock systems need to be extensible through configuration and modularization. To achieve this, the control system relies on a multi-tier architecture with a clear separation between front-end devices and controllers. To minimize time-to-market, the systems rely mostly on COTS hardware and software, including a timing and triggering system and a light-weight software framework to standardize front-end controllers.
* The LIGHT Proton Therapy System is still subject to conformity assessment by AVO's Notified Body as well as clearance by the USA-FDA
 
poster icon Poster TUPHA064 [2.678 MB]  
DOI • reference for this paper ※ https://doi.org/10.18429/JACoW-ICALEPCS2017-TUPHA064  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)  
 
THPHA130 Control and Interlock Systems for the LIGHT Prototype 1683
 
  • R. Moser, M. Cerv, S. Magnoni, H. Pavetits, P. Paz Neira, K. Stachyra
    ADAM SA, Geneva, Switzerland
 
  LIGHT (Linac Image Guided Hadron Technology) is a particle therapy system* developed by Advanced Oncotherapy plc. Accelerator, control and interlock systems are developed by its subsidiary A.D.A.M.SA, a CERN spin-off. The system is being designed to accelerate protons up to 230 MeV using a modular and compact 25-meter-long linear accelerator. It is being designed to operate in pulsed mode where beam properties (energy, pulse charge and spot size) can be changed at 200 Hz. A proof-of-concept accelerator is being assembled and tested at CERN (Geneva, Switzerland). Control and interlock systems are developed using an exploratory prototyping approach and COTS hardware. Requirements for the final LIGHT control and interlock systems are iteratively clarified through creation and refinement of these prototypes. We will continue to support the proof-of-concept accelerator activities while starting to design the final LIGHT control and interlock systems in parallel, building upon the knowledge acquired with the proof-of-concept accelerator. The matured final LIGHT control and interlock systems will gradually replace the prototypes to automate procedures and test the system before deployment
* The LIGHT Proton Therapy System is still subject to conformity assessment by AVO's Notified Body as well as clearance by the USA-FDA
 
poster icon Poster THPHA130 [7.669 MB]  
DOI • reference for this paper ※ https://doi.org/10.18429/JACoW-ICALEPCS2017-THPHA130  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)